Correlation Between Hyundai and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hyundai and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyundai and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hyundai Motor Co and Travere Therapeutics, you can compare the effects of market volatilities on Hyundai and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyundai with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyundai and Travere Therapeutics.
Diversification Opportunities for Hyundai and Travere Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hyundai and Travere is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Hyundai Motor Co and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Hyundai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyundai Motor Co are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Hyundai i.e., Hyundai and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Hyundai and Travere Therapeutics
Assuming the 90 days horizon Hyundai Motor Co is expected to under-perform the Travere Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Hyundai Motor Co is 1.9 times less risky than Travere Therapeutics. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 1,750 in Travere Therapeutics on September 1, 2024 and sell it today you would earn a total of 131.00 from holding Travere Therapeutics or generate 7.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hyundai Motor Co vs. Travere Therapeutics
Performance |
| Timeline |
| Hyundai Motor |
| Travere Therapeutics |
Hyundai and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hyundai and Travere Therapeutics
The main advantage of trading using opposite Hyundai and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyundai position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.The idea behind Hyundai Motor Co and Travere Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |